Rapid emergence of resistance to cefepime during treatment

Clinical Infectious Diseases

Volumn 25, Issue 2, 1997, Pages 339-342

  Limaye, Ajit P ^a   Gautom, Romesh K ^a   Black, Douglas ^a   Fritsche, Thomas R ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTERY THROMBOSIS; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BLOOD CULTURE; CASE REPORT; ENTEROBACTER AEROGENES; HEPATIC ARTERY; HUMAN; LIVER ABSCESS; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; WOUND DRAINAGE;

EID: 0030809452     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516917     Document Type: Article

References (4)

1. Chong Y, Lee K, Kwon OH. In vitro activities of cefepime against Enterobacter cloacae, Serratia marcescens, Pseudomonas aeruginosa, and other aerobic gram-negative bacilli. J Antimicrob Chemother 1993; 32(suppl B):21-9.
2. Sanders WE Jr, Tenney JH, Kessler RE. Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species. Clin Infect Dis 1996; 23:454-61.
3. Marchou B, Michea-Hamzehpour M, Lucain C, Pechère J-C. Development of β-lactam-resistant Enterobacter cloacae in mice. J Infect Dis 1987; 156:369-73.
4. Pechere J-C, Vladoianu IR. Development of resistance during ceftazidime and cefepime therapy in a murine peritonitis model. J Antimicrob Chemother 1992; 29:563-73.